

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 8.57226347 |
| 2 | polyketide metabolic process (GO:0030638) | 8.57226347 |
| 3 | doxorubicin metabolic process (GO:0044598) | 8.57226347 |
| 4 | desmosome organization (GO:0002934) | 7.65204878 |
| 5 | keratinocyte differentiation (GO:0030216) | 7.02499191 |
| 6 | keratinocyte proliferation (GO:0043616) | 6.15627824 |
| 7 | negative regulation of epidermis development (GO:0045683) | 6.07400332 |
| 8 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.77650792 |
| 9 | * multicellular organismal water homeostasis (GO:0050891) | 5.72523475 |
| 10 | peptide cross-linking (GO:0018149) | 5.70577724 |
| 11 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.69787915 |
| 12 | epidermal cell differentiation (GO:0009913) | 5.56083268 |
| 13 | intestinal epithelial cell development (GO:0060576) | 5.49754176 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.47524285 |
| 15 | epidermis development (GO:0008544) | 5.45236211 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.41311835 |
| 17 | rRNA transcription (GO:0009303) | 5.18569144 |
| 18 | muscle organ morphogenesis (GO:0048644) | 5.17860674 |
| 19 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.13469940 |
| 20 | maintenance of protein location in nucleus (GO:0051457) | 5.03863069 |
| 21 | regulation of response to osmotic stress (GO:0047484) | 4.96723484 |
| 22 | arachidonic acid secretion (GO:0050482) | 4.94022645 |
| 23 | icosanoid secretion (GO:0032309) | 4.94022645 |
| 24 | * water homeostasis (GO:0030104) | 4.92291848 |
| 25 | somite rostral/caudal axis specification (GO:0032525) | 4.92185204 |
| 26 | cytidine catabolic process (GO:0006216) | 4.74138682 |
| 27 | cytidine deamination (GO:0009972) | 4.74138682 |
| 28 | cytidine metabolic process (GO:0046087) | 4.74138682 |
| 29 | interferon-gamma secretion (GO:0072643) | 4.66046813 |
| 30 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.61368121 |
| 31 | detection of temperature stimulus (GO:0016048) | 4.57261621 |
| 32 | protein localization to kinetochore (GO:0034501) | 4.55921944 |
| 33 | notochord development (GO:0030903) | 4.53886409 |
| 34 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.52382366 |
| 35 | lipoxygenase pathway (GO:0019372) | 4.50595127 |
| 36 | keratinocyte development (GO:0003334) | 4.42581557 |
| 37 | * establishment of skin barrier (GO:0061436) | 4.38685157 |
| 38 | negative regulation of telomerase activity (GO:0051974) | 4.34958212 |
| 39 | * regulation of water loss via skin (GO:0033561) | 4.29007664 |
| 40 | GDP-mannose metabolic process (GO:0019673) | 4.26821935 |
| 41 | hormone catabolic process (GO:0042447) | 4.20959466 |
| 42 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.17432159 |
| 43 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.16998223 |
| 44 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.12105322 |
| 45 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.11751738 |
| 46 | detection of bacterium (GO:0016045) | 4.11543215 |
| 47 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.10942437 |
| 48 | response to water (GO:0009415) | 4.06344495 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 4.04170777 |
| 50 | rRNA modification (GO:0000154) | 3.94658819 |
| 51 | icosanoid transport (GO:0071715) | 3.93338110 |
| 52 | fatty acid derivative transport (GO:1901571) | 3.93338110 |
| 53 | keratinization (GO:0031424) | 3.90170821 |
| 54 | negative regulation of interleukin-2 production (GO:0032703) | 3.88257320 |
| 55 | regulation of translation in response to stress (GO:0043555) | 3.87554256 |
| 56 | histone H4-K12 acetylation (GO:0043983) | 3.86305780 |
| 57 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.84564216 |
| 58 | regulation of cilium movement (GO:0003352) | 3.82795491 |
| 59 | rRNA methylation (GO:0031167) | 3.82768610 |
| 60 | histone H4-K8 acetylation (GO:0043982) | 3.82170731 |
| 61 | histone H4-K5 acetylation (GO:0043981) | 3.82170731 |
| 62 | * positive regulation of epidermis development (GO:0045684) | 3.80806968 |
| 63 | hemidesmosome assembly (GO:0031581) | 3.73307082 |
| 64 | detection of other organism (GO:0098543) | 3.71745153 |
| 65 | proline transport (GO:0015824) | 3.71097033 |
| 66 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.70744101 |
| 67 | viral transcription (GO:0019083) | 3.67615508 |
| 68 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.67612945 |
| 69 | mitotic sister chromatid segregation (GO:0000070) | 3.61276657 |
| 70 | quinone metabolic process (GO:1901661) | 3.60425632 |
| 71 | cullin deneddylation (GO:0010388) | 3.57172958 |
| 72 | positive regulation of odontogenesis (GO:0042482) | 3.56234074 |
| 73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55978538 |
| 74 | nucleoside transmembrane transport (GO:1901642) | 3.55947176 |
| 75 | sphingoid metabolic process (GO:0046519) | 3.52054918 |
| 76 | trophectodermal cell differentiation (GO:0001829) | 3.51719952 |
| 77 | regulation of G0 to G1 transition (GO:0070316) | 3.50219602 |
| 78 | heterochromatin organization (GO:0070828) | 3.48743186 |
| 79 | protein polyglutamylation (GO:0018095) | 3.47733531 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.45221962 |
| 81 | translational termination (GO:0006415) | 3.45154796 |
| 82 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.42958979 |
| 83 | hair cycle (GO:0042633) | 3.40172448 |
| 84 | molting cycle (GO:0042303) | 3.40172448 |
| 85 | DNA replication checkpoint (GO:0000076) | 3.38872557 |
| 86 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38414207 |
| 87 | phenol-containing compound catabolic process (GO:0019336) | 3.37328122 |
| 88 | response to dietary excess (GO:0002021) | 3.35539967 |
| 89 | intermediate filament cytoskeleton organization (GO:0045104) | 3.35288703 |
| 90 | intermediate filament organization (GO:0045109) | 3.34833728 |
| 91 | coenzyme catabolic process (GO:0009109) | 3.34673853 |
| 92 | protein localization to chromosome, centromeric region (GO:0071459) | 3.28657278 |
| 93 | skin morphogenesis (GO:0043589) | 3.26781311 |
| 94 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.26005192 |
| 95 | cyclooxygenase pathway (GO:0019371) | 3.25403177 |
| 96 | gap junction assembly (GO:0016264) | 3.24997698 |
| 97 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.24440251 |
| 98 | intermediate filament-based process (GO:0045103) | 3.24010317 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.23728523 |
| 100 | formation of translation preinitiation complex (GO:0001731) | 3.19831683 |
| 101 | diol metabolic process (GO:0034311) | 3.19001638 |
| 102 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.18842138 |
| 103 | ribosome biogenesis (GO:0042254) | 3.16981838 |
| 104 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.16775494 |
| 105 | protein deneddylation (GO:0000338) | 3.16529179 |
| 106 | ectoderm development (GO:0007398) | 3.16137550 |
| 107 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.14285452 |
| 108 | regulation of telomerase activity (GO:0051972) | 3.12331857 |
| 109 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.09546273 |
| 110 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08248887 |
| 111 | negative regulation of telomere maintenance (GO:0032205) | 3.08070527 |
| 112 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.07852882 |
| 113 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.06931900 |
| 114 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.06931900 |
| 115 | linoleic acid metabolic process (GO:0043651) | 3.06806310 |
| 116 | protein targeting to ER (GO:0045047) | 3.05278085 |
| 117 | negative regulation of interferon-gamma production (GO:0032689) | 3.04656305 |
| 118 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.03606245 |
| 119 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.03252922 |
| 120 | cotranslational protein targeting to membrane (GO:0006613) | 3.03070474 |
| 121 | pseudouridine synthesis (GO:0001522) | 3.01185941 |
| 122 | fatty acid elongation (GO:0030497) | 2.99485384 |
| 123 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.98951545 |
| 124 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.98951545 |
| 125 | transepithelial transport (GO:0070633) | 2.98609923 |
| 126 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.97832188 |
| 127 | biotin metabolic process (GO:0006768) | 2.96627615 |
| 128 | viral life cycle (GO:0019058) | 2.96339485 |
| 129 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95345277 |
| 130 | translational elongation (GO:0006414) | 2.95000136 |
| 131 | nuclear pore complex assembly (GO:0051292) | 2.90699832 |
| 132 | ATP synthesis coupled proton transport (GO:0015986) | 2.90675836 |
| 133 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.90675836 |
| 134 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90406668 |
| 135 | retinoic acid receptor signaling pathway (GO:0048384) | 2.88977513 |
| 136 | protein localization to endoplasmic reticulum (GO:0070972) | 2.88680076 |
| 137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80893555 |
| 138 | regulation of keratinocyte differentiation (GO:0045616) | 2.77252979 |
| 139 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.72293944 |
| 140 | oligosaccharide catabolic process (GO:0009313) | 2.71070066 |
| 141 | phosphatidylserine metabolic process (GO:0006658) | 2.67452892 |
| 142 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.66793477 |
| 143 | ribosomal large subunit biogenesis (GO:0042273) | 2.66556663 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.64752580 |
| 145 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.64573367 |
| 146 | ribosomal small subunit assembly (GO:0000028) | 2.63419514 |
| 147 | nucleotide salvage (GO:0043173) | 2.58373812 |
| 148 | viral protein processing (GO:0019082) | 2.58012538 |
| 149 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.57613139 |
| 150 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.56732748 |
| 151 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.55624038 |
| 152 | virion assembly (GO:0019068) | 2.55338001 |
| 153 | amyloid precursor protein catabolic process (GO:0042987) | 2.54011318 |
| 154 | * regulation of epidermis development (GO:0045682) | 2.53689210 |
| 155 | regulation of epidermal cell differentiation (GO:0045604) | 2.53368767 |
| 156 | translational initiation (GO:0006413) | 2.51722447 |
| 157 | pyrimidine-containing compound salvage (GO:0008655) | 2.50251283 |
| 158 | pyrimidine nucleoside salvage (GO:0043097) | 2.50251283 |
| 159 | positive regulation of hair cycle (GO:0042635) | 2.48539153 |
| 160 | positive regulation of hair follicle development (GO:0051798) | 2.48539153 |
| 161 | regulation of natural killer cell differentiation (GO:0032823) | 2.44713763 |
| 162 | response to peptidoglycan (GO:0032494) | 2.42975742 |
| 163 | cellular protein complex disassembly (GO:0043624) | 2.41606057 |
| 164 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40365012 |
| 165 | regulation of monocyte chemotaxis (GO:0090025) | 2.36304339 |
| 166 | surfactant homeostasis (GO:0043129) | 2.35878059 |
| 167 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.35160679 |
| 168 | cell-substrate junction assembly (GO:0007044) | 2.34159866 |
| 169 | amino sugar catabolic process (GO:0046348) | 2.33797445 |
| 170 | polarized epithelial cell differentiation (GO:0030859) | 2.33478384 |
| 171 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.32445989 |
| 172 | establishment of tissue polarity (GO:0007164) | 2.32100256 |
| 173 | establishment of planar polarity (GO:0001736) | 2.32100256 |
| 174 | epithelium development (GO:0060429) | 2.30777314 |
| 175 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.30311730 |
| 176 | mitotic nuclear envelope reassembly (GO:0007084) | 2.27926015 |
| 177 | nuclear envelope reassembly (GO:0031468) | 2.27926015 |
| 178 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.27698666 |
| 179 | defense response to fungus (GO:0050832) | 2.25978369 |
| 180 | nucleoside salvage (GO:0043174) | 2.25445712 |
| 181 | termination of RNA polymerase III transcription (GO:0006386) | 2.24568059 |
| 182 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.24568059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.94446590 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.63501767 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.63501767 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.63501767 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.53228056 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.43281793 |
| 7 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.07610739 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.84536229 |
| 9 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.77558280 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.73562009 |
| 11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.69981218 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66091148 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.54401021 |
| 14 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.48540583 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.30313931 |
| 16 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.25562604 |
| 17 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.23190839 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16334667 |
| 19 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.10878671 |
| 20 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.98987356 |
| 21 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.98657561 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.93522539 |
| 23 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.91192792 |
| 24 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.86754379 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85085976 |
| 26 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.83094295 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.82952492 |
| 28 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.79260036 |
| 29 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.78886060 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75608951 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.69911397 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.69911397 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.65283338 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63086469 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60602227 |
| 36 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.59048728 |
| 37 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58760191 |
| 38 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58610134 |
| 39 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.54629575 |
| 40 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49771798 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49737966 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49578953 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.48148145 |
| 44 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.46662435 |
| 45 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44582504 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.41233324 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40793433 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.39850395 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.38491943 |
| 50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37908738 |
| 51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37626539 |
| 52 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.37445091 |
| 53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36275662 |
| 54 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35132172 |
| 55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34337439 |
| 56 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.33746673 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33150217 |
| 58 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.33146467 |
| 59 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32480146 |
| 60 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32082213 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30360514 |
| 62 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.27515099 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25468950 |
| 64 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25056832 |
| 65 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23602729 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23041322 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23006738 |
| 68 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22856476 |
| 69 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.21766682 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19747079 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18798082 |
| 72 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.18218130 |
| 73 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.17556427 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17493441 |
| 75 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.17434562 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17433621 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17247836 |
| 78 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16339641 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16291594 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15126697 |
| 81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15122173 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.14575277 |
| 83 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14430486 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14165314 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13780398 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13657313 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12801673 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12569286 |
| 89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12153582 |
| 90 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10905724 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08822146 |
| 92 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08375011 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08360901 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08032585 |
| 95 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07743834 |
| 96 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07664401 |
| 97 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.07397292 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06191540 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05483041 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05180891 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05037550 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04836483 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.04262645 |
| 104 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04262358 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03940677 |
| 106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03788571 |
| 107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03720497 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03272967 |
| 109 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01523282 |
| 110 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.01382799 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.01313190 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00606307 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00219784 |
| 114 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99987247 |
| 115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99285038 |
| 116 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98649007 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98471036 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98244910 |
| 119 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98189056 |
| 120 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97234973 |
| 121 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.96190124 |
| 122 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.95365979 |
| 123 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94410480 |
| 124 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94369673 |
| 125 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.94352440 |
| 126 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93557010 |
| 127 | MYC_22102868_ChIP-Seq_BL_Human | 0.93260745 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93245258 |
| 129 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92919886 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92617747 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92113736 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91653252 |
| 133 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91459617 |
| 134 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91436631 |
| 135 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91299534 |
| 136 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90705927 |
| 137 | MAF_26560356_Chip-Seq_TH1_Human | 0.90318303 |
| 138 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88860325 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88168036 |
| 140 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87970358 |
| 141 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86981734 |
| 142 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86251442 |
| 143 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84854311 |
| 144 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.84801482 |
| 145 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84617236 |
| 146 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82944914 |
| 147 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82832635 |
| 148 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81782559 |
| 149 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81765485 |
| 150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81279415 |
| 151 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.81233535 |
| 152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80610219 |
| 153 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80029816 |
| 154 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78980103 |
| 155 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.78366758 |
| 156 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.77947127 |
| 157 | P68_20966046_ChIP-Seq_HELA_Human | 0.77765790 |
| 158 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.77182096 |
| 159 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.75887062 |
| 160 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75654200 |
| 161 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74279975 |
| 162 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72548848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 4.74491527 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.61170645 |
| 3 | MP0002254_reproductive_system_inflammat | 4.13210279 |
| 4 | MP0004858_abnormal_nervous_system | 3.99358860 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.74241230 |
| 6 | MP0003011_delayed_dark_adaptation | 3.36286546 |
| 7 | MP0005501_abnormal_skin_physiology | 2.90392567 |
| 8 | MP0004381_abnormal_hair_follicle | 2.78074599 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.65747673 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.53128418 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.51726092 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.36165695 |
| 13 | MP0005275_abnormal_skin_tensile | 2.34415795 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.27311389 |
| 15 | MP0002098_abnormal_vibrissa_morphology | 2.22818243 |
| 16 | MP0005394_taste/olfaction_phenotype | 2.21832298 |
| 17 | MP0005499_abnormal_olfactory_system | 2.21832298 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.14728533 |
| 19 | MP0003941_abnormal_skin_development | 2.13547184 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.12254900 |
| 21 | MP0000579_abnormal_nail_morphology | 2.10415140 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.07143377 |
| 23 | MP0005451_abnormal_body_composition | 2.03914605 |
| 24 | MP0010678_abnormal_skin_adnexa | 2.02695302 |
| 25 | MP0001216_abnormal_epidermal_layer | 1.99400674 |
| 26 | MP0000762_abnormal_tongue_morphology | 1.98822823 |
| 27 | MP0010771_integument_phenotype | 1.98693013 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.94081470 |
| 29 | MP0002736_abnormal_nociception_after | 1.91476732 |
| 30 | MP0003315_abnormal_perineum_morphology | 1.83139759 |
| 31 | MP0000647_abnormal_sebaceous_gland | 1.80617955 |
| 32 | MP0000383_abnormal_hair_follicle | 1.79617172 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.79381527 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.77693398 |
| 35 | MP0000377_abnormal_hair_follicle | 1.77652025 |
| 36 | MP0000566_synostosis | 1.75598432 |
| 37 | MP0003693_abnormal_embryo_hatching | 1.75261609 |
| 38 | MP0001849_ear_inflammation | 1.66417834 |
| 39 | MP0002060_abnormal_skin_morphology | 1.63769871 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.60322933 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.59342592 |
| 42 | MP0008260_abnormal_autophagy | 1.58886981 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.52515746 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.52208105 |
| 45 | MP0000427_abnormal_hair_cycle | 1.46697033 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.43909831 |
| 47 | MP0010030_abnormal_orbit_morphology | 1.42999667 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.41172884 |
| 49 | MP0002751_abnormal_autonomic_nervous | 1.39467202 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.39414702 |
| 51 | MP0000678_abnormal_parathyroid_gland | 1.35863418 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.30858973 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.28420737 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.27014284 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.26951174 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.22958292 |
| 57 | MP0004270_analgesia | 1.21535606 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.18742354 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.18708037 |
| 60 | MP0003938_abnormal_ear_development | 1.17716483 |
| 61 | MP0008932_abnormal_embryonic_tissue | 1.16216152 |
| 62 | MP0001672_abnormal_embryogenesis/_devel | 1.11436941 |
| 63 | MP0005380_embryogenesis_phenotype | 1.11436941 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.09190130 |
| 65 | MP0003878_abnormal_ear_physiology | 1.09190130 |
| 66 | MP0000685_abnormal_immune_system | 1.06955192 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.05137655 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 1.04962450 |
| 69 | MP0005257_abnormal_intraocular_pressure | 1.03606805 |
| 70 | MP0004043_abnormal_pH_regulation | 1.03393135 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.03086579 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 1.01287272 |
| 73 | MP0008057_abnormal_DNA_replication | 0.99830426 |
| 74 | MP0005023_abnormal_wound_healing | 0.98958192 |
| 75 | MP0000350_abnormal_cell_proliferation | 0.97977168 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 0.97879416 |
| 77 | MP0001243_abnormal_dermal_layer | 0.97101084 |
| 78 | MP0003122_maternal_imprinting | 0.95494188 |
| 79 | MP0003984_embryonic_growth_retardation | 0.91995073 |
| 80 | MP0001970_abnormal_pain_threshold | 0.90961384 |
| 81 | MP0004947_skin_inflammation | 0.90201754 |
| 82 | MP0001851_eye_inflammation | 0.88316574 |
| 83 | MP0005409_darkened_coat_color | 0.88043539 |
| 84 | MP0009931_abnormal_skin_appearance | 0.86895325 |
| 85 | MP0004885_abnormal_endolymph | 0.86794598 |
| 86 | MP0000467_abnormal_esophagus_morphology | 0.86403962 |
| 87 | MP0002970_abnormal_white_adipose | 0.85780355 |
| 88 | MP0000367_abnormal_coat/_hair | 0.83113098 |
| 89 | MP0002132_abnormal_respiratory_system | 0.82691287 |
| 90 | MP0002233_abnormal_nose_morphology | 0.82664139 |
| 91 | MP0001873_stomach_inflammation | 0.82504721 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 0.79334672 |
| 93 | MP0003436_decreased_susceptibility_to | 0.78781588 |
| 94 | MP0009053_abnormal_anal_canal | 0.77994710 |
| 95 | MP0002085_abnormal_embryonic_tissue | 0.77978433 |
| 96 | MP0000858_altered_metastatic_potential | 0.77597830 |
| 97 | MP0003755_abnormal_palate_morphology | 0.77125897 |
| 98 | MP0001270_distended_abdomen | 0.77114639 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.76848192 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 0.76671163 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.75811026 |
| 102 | MP0005408_hypopigmentation | 0.75494703 |
| 103 | MP0009785_altered_susceptibility_to | 0.75450961 |
| 104 | MP0005387_immune_system_phenotype | 0.74644649 |
| 105 | MP0001790_abnormal_immune_system | 0.74644649 |
| 106 | MP0000490_abnormal_crypts_of | 0.73320118 |
| 107 | MP0003077_abnormal_cell_cycle | 0.73214335 |
| 108 | MP0000749_muscle_degeneration | 0.73143815 |
| 109 | MP0002084_abnormal_developmental_patter | 0.71618508 |
| 110 | MP0005025_abnormal_response_to | 0.70322510 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.70069651 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.69812385 |
| 113 | MP0002932_abnormal_joint_morphology | 0.69748341 |
| 114 | MP0001730_embryonic_growth_arrest | 0.69657305 |
| 115 | MP0005266_abnormal_metabolism | 0.69397768 |
| 116 | MP0008770_decreased_survivor_rate | 0.68986720 |
| 117 | MP0003724_increased_susceptibility_to | 0.66121137 |
| 118 | MP0000627_abnormal_mammary_gland | 0.65042544 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.64619800 |
| 120 | MP0009840_abnormal_foam_cell | 0.64546346 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.64300829 |
| 122 | MP0001881_abnormal_mammary_gland | 0.63691793 |
| 123 | MP0003111_abnormal_nucleus_morphology | 0.63371447 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.63130130 |
| 125 | MP0005310_abnormal_salivary_gland | 0.60160961 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.60038962 |
| 127 | MP0000470_abnormal_stomach_morphology | 0.59902708 |
| 128 | MP0002249_abnormal_larynx_morphology | 0.59768680 |
| 129 | MP0002114_abnormal_axial_skeleton | 0.59686278 |
| 130 | MP0000432_abnormal_head_morphology | 0.58923936 |
| 131 | MP0001191_abnormal_skin_condition | 0.58919845 |
| 132 | MP0010155_abnormal_intestine_physiology | 0.58650112 |
| 133 | MP0009379_abnormal_foot_pigmentation | 0.58551219 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.58352893 |
| 135 | MP0008872_abnormal_physiological_respon | 0.58249139 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.58135920 |
| 137 | MP0000358_abnormal_cell_content/ | 0.57044812 |
| 138 | MP0002452_abnormal_antigen_presenting | 0.55824106 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.54725574 |
| 140 | MP0005000_abnormal_immune_tolerance | 0.52269629 |
| 141 | MP0002419_abnormal_innate_immunity | 0.51390058 |
| 142 | MP0002723_abnormal_immune_serum | 0.50617811 |
| 143 | MP0003075_altered_response_to | 0.47882568 |
| 144 | MP0001800_abnormal_humoral_immune | 0.46872678 |
| 145 | MP0003786_premature_aging | 0.45572262 |
| 146 | MP0001819_abnormal_immune_cell | 0.45127792 |
| 147 | MP0001764_abnormal_homeostasis | 0.44256824 |
| 148 | MP0001346_abnormal_lacrimal_gland | 0.43413941 |
| 149 | MP0002420_abnormal_adaptive_immunity | 0.43038366 |
| 150 | MP0001756_abnormal_urination | 0.42196656 |
| 151 | MP0009384_cardiac_valve_regurgitation | 0.41860659 |
| 152 | MP0006082_CNS_inflammation | 0.41808542 |
| 153 | MP0001340_abnormal_eyelid_morphology | 0.41631411 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.40348105 |
| 155 | MP0001188_hyperpigmentation | 0.39915425 |
| 156 | MP0008469_abnormal_protein_level | 0.39846746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oral leukoplakia (HP:0002745) | 6.73945059 |
| 2 | Bilateral microphthalmos (HP:0007633) | 6.23924048 |
| 3 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.87868836 |
| 4 | Erythroderma (HP:0001019) | 5.60938481 |
| 5 | Alopecia of scalp (HP:0002293) | 5.18610810 |
| 6 | Thick nail (HP:0001805) | 4.96412131 |
| 7 | Multiple enchondromatosis (HP:0005701) | 4.56104633 |
| 8 | Parakeratosis (HP:0001036) | 4.55193526 |
| 9 | Milia (HP:0001056) | 4.51024496 |
| 10 | Hypotrichosis (HP:0001006) | 4.18375674 |
| 11 | Abnormality of the lower motor neuron (HP:0002366) | 3.87089205 |
| 12 | Abnormal hair laboratory examination (HP:0003328) | 3.84646331 |
| 13 | Abnormality of the axillary hair (HP:0100134) | 3.75850841 |
| 14 | Abnormality of secondary sexual hair (HP:0009888) | 3.75850841 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 3.72384791 |
| 16 | Abnormal hemoglobin (HP:0011902) | 3.71325371 |
| 17 | Corneal erosion (HP:0200020) | 3.63674206 |
| 18 | Abnormal blistering of the skin (HP:0008066) | 3.56779139 |
| 19 | Rib fusion (HP:0000902) | 3.54817527 |
| 20 | Hepatoblastoma (HP:0002884) | 3.52761614 |
| 21 | Trismus (HP:0000211) | 3.41658732 |
| 22 | Lip pit (HP:0100267) | 3.40264080 |
| 23 | Sparse eyelashes (HP:0000653) | 3.39348230 |
| 24 | Curly hair (HP:0002212) | 3.32949483 |
| 25 | Testicular atrophy (HP:0000029) | 3.31144665 |
| 26 | Abnormality of nail color (HP:0100643) | 3.28032861 |
| 27 | Ependymoma (HP:0002888) | 3.24850365 |
| 28 | Increased IgE level (HP:0003212) | 3.24576626 |
| 29 | Ectropion (HP:0000656) | 3.24040066 |
| 30 | Abnormality of the salivary glands (HP:0010286) | 3.23350317 |
| 31 | Pustule (HP:0200039) | 3.16709143 |
| 32 | Amniotic constriction ring (HP:0009775) | 3.16098688 |
| 33 | Abnormality of placental membranes (HP:0011409) | 3.16098688 |
| 34 | Palmoplantar keratoderma (HP:0000982) | 2.99957935 |
| 35 | Increased connective tissue (HP:0009025) | 2.96756601 |
| 36 | Rhabdomyosarcoma (HP:0002859) | 2.94459788 |
| 37 | Hypohidrosis (HP:0000966) | 2.87253443 |
| 38 | Villous atrophy (HP:0011473) | 2.84737956 |
| 39 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.84737956 |
| 40 | Nasolacrimal duct obstruction (HP:0000579) | 2.84728637 |
| 41 | Ridged nail (HP:0001807) | 2.81204931 |
| 42 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.80367665 |
| 43 | Partial duplication of thumb phalanx (HP:0009944) | 2.79120974 |
| 44 | Woolly hair (HP:0002224) | 2.77325557 |
| 45 | Premature ovarian failure (HP:0008209) | 2.75509053 |
| 46 | Neoplasm of striated muscle (HP:0009728) | 2.75191171 |
| 47 | Fasciculations (HP:0002380) | 2.74796087 |
| 48 | Bifid tongue (HP:0010297) | 2.74625122 |
| 49 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.73711048 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72831149 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72831149 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72831149 |
| 53 | Fused cervical vertebrae (HP:0002949) | 2.72294412 |
| 54 | Short humerus (HP:0005792) | 2.70359791 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.67982324 |
| 56 | Conjunctival hamartoma (HP:0100780) | 2.66295512 |
| 57 | Malnutrition (HP:0004395) | 2.60448952 |
| 58 | Natal tooth (HP:0000695) | 2.59343841 |
| 59 | Follicular hyperkeratosis (HP:0007502) | 2.58748853 |
| 60 | Dysautonomia (HP:0002459) | 2.58692799 |
| 61 | Concave nail (HP:0001598) | 2.56555885 |
| 62 | Nail dystrophy (HP:0008404) | 2.54992439 |
| 63 | Gangrene (HP:0100758) | 2.53188360 |
| 64 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.52371221 |
| 65 | Upper limb muscle weakness (HP:0003484) | 2.50471099 |
| 66 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.50094495 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.49834457 |
| 68 | Muscle fibrillation (HP:0010546) | 2.49471593 |
| 69 | Tongue fasciculations (HP:0001308) | 2.49059328 |
| 70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.48682050 |
| 71 | Hypoplasia of the fovea (HP:0007750) | 2.48682050 |
| 72 | Periauricular skin pits (HP:0100277) | 2.48377917 |
| 73 | Preauricular pit (HP:0004467) | 2.48377917 |
| 74 | Anomalous pulmonary venous return (HP:0010772) | 2.47293099 |
| 75 | Fragile nails (HP:0001808) | 2.45723219 |
| 76 | Rectovaginal fistula (HP:0000143) | 2.45355069 |
| 77 | Rectal fistula (HP:0100590) | 2.45355069 |
| 78 | Plantar hyperkeratosis (HP:0007556) | 2.44953214 |
| 79 | Onycholysis (HP:0001806) | 2.44376177 |
| 80 | Pili torti (HP:0003777) | 2.43400123 |
| 81 | Atrophic scars (HP:0001075) | 2.43076999 |
| 82 | Horizontal nystagmus (HP:0000666) | 2.41577063 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.39161679 |
| 84 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.35894651 |
| 85 | Difficulty running (HP:0009046) | 2.35131658 |
| 86 | Microretrognathia (HP:0000308) | 2.35048334 |
| 87 | Skin pits (HP:0100276) | 2.34656191 |
| 88 | Partial duplication of the phalanx of hand (HP:0009999) | 2.34324705 |
| 89 | Areflexia of lower limbs (HP:0002522) | 2.30145837 |
| 90 | Adenoma sebaceum (HP:0009720) | 2.29481150 |
| 91 | Angiofibromas (HP:0010615) | 2.29481150 |
| 92 | Sensory axonal neuropathy (HP:0003390) | 2.27661651 |
| 93 | Brittle hair (HP:0002299) | 2.27315341 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 2.27270821 |
| 95 | Ventricular tachycardia (HP:0004756) | 2.26565672 |
| 96 | Dry hair (HP:0011359) | 2.25027675 |
| 97 | Abnormality of the lacrimal duct (HP:0011481) | 2.24612673 |
| 98 | Hyperhidrosis (HP:0000975) | 2.23552958 |
| 99 | Abnormal lung lobation (HP:0002101) | 2.23160007 |
| 100 | Erythema (HP:0010783) | 2.22699490 |
| 101 | Abnormality of the musculature of the hand (HP:0001421) | 2.21419635 |
| 102 | Distal lower limb muscle weakness (HP:0009053) | 2.19738208 |
| 103 | Intestinal fistula (HP:0100819) | 2.19286262 |
| 104 | Preauricular skin tag (HP:0000384) | 2.19120627 |
| 105 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.18754400 |
| 106 | Ulnar claw (HP:0001178) | 2.17495502 |
| 107 | Tetraplegia (HP:0002445) | 2.14523218 |
| 108 | Absent eyelashes (HP:0000561) | 2.14325180 |
| 109 | Palmoplantar hyperkeratosis (HP:0000972) | 2.13744627 |
| 110 | Impaired pain sensation (HP:0007328) | 2.08695518 |
| 111 | Abnormality of pain sensation (HP:0010832) | 2.08695518 |
| 112 | Sparse scalp hair (HP:0002209) | 2.07409947 |
| 113 | Astrocytoma (HP:0009592) | 2.06680526 |
| 114 | Abnormality of the astrocytes (HP:0100707) | 2.06680526 |
| 115 | Pruritus (HP:0000989) | 2.05515954 |
| 116 | Carious teeth (HP:0000670) | 2.05132765 |
| 117 | Vaginal fistula (HP:0004320) | 2.04651538 |
| 118 | Achilles tendon contracture (HP:0001771) | 2.02608850 |
| 119 | Hypoplasia of dental enamel (HP:0006297) | 2.02123919 |
| 120 | Selective tooth agenesis (HP:0001592) | 2.01972338 |
| 121 | Embryonal renal neoplasm (HP:0011794) | 2.01964272 |
| 122 | Palmar hyperkeratosis (HP:0010765) | 2.00122385 |
| 123 | Abnormality of the pulmonary veins (HP:0011718) | 1.99738262 |
| 124 | Furrowed tongue (HP:0000221) | 1.99700011 |
| 125 | EMG: neuropathic changes (HP:0003445) | 1.98898501 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 1.98471788 |
| 127 | Advanced eruption of teeth (HP:0006288) | 1.98379439 |
| 128 | Shawl scrotum (HP:0000049) | 1.97733688 |
| 129 | Anonychia (HP:0001798) | 1.96263462 |
| 130 | Oligodontia (HP:0000677) | 1.95902615 |
| 131 | Cheilitis (HP:0100825) | 1.95209530 |
| 132 | Urticaria (HP:0001025) | 1.94707836 |
| 133 | Glossoptosis (HP:0000162) | 1.94611777 |
| 134 | Chromsome breakage (HP:0040012) | 1.92858618 |
| 135 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.92807966 |
| 136 | Hypoplastic scapulae (HP:0000882) | 1.92807966 |
| 137 | Amelogenesis imperfecta (HP:0000705) | 1.90450282 |
| 138 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.90411558 |
| 139 | Generalized hypotonia (HP:0001290) | 1.90229841 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89433271 |
| 141 | Abnormality of the fovea (HP:0000493) | 1.88771121 |
| 142 | Dehydration (HP:0001944) | 1.87214916 |
| 143 | Skin ulcer (HP:0200042) | 1.86635071 |
| 144 | Septate vagina (HP:0001153) | 1.85650397 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 1.84777446 |
| 146 | Eczematoid dermatitis (HP:0000976) | 1.82426668 |
| 147 | Absent hair (HP:0002298) | 1.82077849 |
| 148 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81794329 |
| 149 | Hypergammaglobulinemia (HP:0010702) | 1.80513829 |
| 150 | Abnormality of hair growth rate (HP:0011363) | 1.79870589 |
| 151 | Slow-growing hair (HP:0002217) | 1.79870589 |
| 152 | Axonal loss (HP:0003447) | 1.79797896 |
| 153 | Blepharitis (HP:0000498) | 1.68809133 |
| 154 | Abnormal number of erythroid precursors (HP:0012131) | 1.67232933 |
| 155 | Verrucae (HP:0200043) | 1.66476559 |
| 156 | Papilloma (HP:0012740) | 1.66476559 |
| 157 | Seborrheic dermatitis (HP:0001051) | 1.63829250 |
| 158 | Acanthosis nigricans (HP:0000956) | 1.63057934 |
| 159 | Aplasia cutis congenita (HP:0001057) | 1.62578112 |
| 160 | Abnormality of the fingernails (HP:0001231) | 1.62560684 |
| 161 | Vacuolated lymphocytes (HP:0001922) | 1.60831719 |
| 162 | Popliteal pterygium (HP:0009756) | 1.59329940 |
| 163 | Abnormality of the neuromuscular junction (HP:0003398) | 1.59029435 |
| 164 | Fatigable weakness (HP:0003473) | 1.59029435 |
| 165 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.55270341 |
| 166 | Dysostosis multiplex (HP:0000943) | 1.54557675 |
| 167 | Fine hair (HP:0002213) | 1.53879034 |
| 168 | Abnormality of the dental root (HP:0006486) | 1.53474078 |
| 169 | Taurodontia (HP:0000679) | 1.53474078 |
| 170 | Abnormality of permanent molar morphology (HP:0011071) | 1.53474078 |
| 171 | Squamous cell carcinoma (HP:0002860) | 1.53161109 |
| 172 | Hypoplastic labia majora (HP:0000059) | 1.51686341 |
| 173 | Hypokinesia (HP:0002375) | 1.46320723 |
| 174 | Dry skin (HP:0000958) | 1.45090228 |
| 175 | Corneal dystrophy (HP:0001131) | 1.44830577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 6.24468479 |
| 2 | CDK12 | 6.09404588 |
| 3 | ERN1 | 3.85151390 |
| 4 | GRK6 | 3.57160169 |
| 5 | EPHA2 | 3.21669259 |
| 6 | GRK1 | 3.11590485 |
| 7 | ADRBK2 | 3.02815246 |
| 8 | VRK2 | 2.86024749 |
| 9 | MAPKAPK3 | 2.70404721 |
| 10 | SIK1 | 2.68234466 |
| 11 | MATK | 2.50642921 |
| 12 | TTK | 2.40225865 |
| 13 | IRAK3 | 2.40062634 |
| 14 | MST1R | 2.06083461 |
| 15 | NTRK1 | 2.03875366 |
| 16 | STK10 | 1.97356913 |
| 17 | SMG1 | 1.97138274 |
| 18 | MAP3K9 | 1.90832347 |
| 19 | TNK2 | 1.77741195 |
| 20 | RPS6KB2 | 1.74442233 |
| 21 | TGFBR2 | 1.72105324 |
| 22 | PRKD2 | 1.72069403 |
| 23 | TLK1 | 1.70499977 |
| 24 | PRKG2 | 1.70431855 |
| 25 | CSF1R | 1.66903203 |
| 26 | GRK7 | 1.66258398 |
| 27 | TGFBR1 | 1.65384001 |
| 28 | PBK | 1.64962144 |
| 29 | MST4 | 1.54607167 |
| 30 | AKT3 | 1.53379386 |
| 31 | IKBKB | 1.52538060 |
| 32 | LATS2 | 1.49626875 |
| 33 | MAPKAPK5 | 1.46496696 |
| 34 | MAPK7 | 1.46319640 |
| 35 | MOS | 1.45949133 |
| 36 | NME1 | 1.44666473 |
| 37 | TYRO3 | 1.44431969 |
| 38 | MAP3K6 | 1.43065592 |
| 39 | TESK2 | 1.40643567 |
| 40 | TRIB3 | 1.37771205 |
| 41 | TBK1 | 1.33375300 |
| 42 | ADRBK1 | 1.29522535 |
| 43 | TAF1 | 1.29483377 |
| 44 | IRAK2 | 1.29319021 |
| 45 | ABL2 | 1.24534795 |
| 46 | WNK1 | 1.22796037 |
| 47 | CDK7 | 1.21243568 |
| 48 | FGFR3 | 1.16545964 |
| 49 | MAP2K6 | 1.13659934 |
| 50 | MAP3K2 | 1.13274188 |
| 51 | MAP4K1 | 1.12395357 |
| 52 | STK16 | 1.12351318 |
| 53 | FER | 1.07288814 |
| 54 | MAP2K3 | 1.07206598 |
| 55 | IKBKE | 1.06146577 |
| 56 | EPHB1 | 1.04837587 |
| 57 | CAMK4 | 1.02592215 |
| 58 | MAP3K14 | 0.99306247 |
| 59 | HIPK2 | 0.98743416 |
| 60 | PAK4 | 0.98722593 |
| 61 | MAP4K2 | 0.96098954 |
| 62 | PIM2 | 0.93455230 |
| 63 | EIF2AK1 | 0.91033899 |
| 64 | LMTK2 | 0.90581925 |
| 65 | MAPK15 | 0.90240639 |
| 66 | MET | 0.89072518 |
| 67 | PRKCI | 0.88629942 |
| 68 | KSR2 | 0.88548874 |
| 69 | BUB1 | 0.88037964 |
| 70 | AURKA | 0.87411770 |
| 71 | MAP2K4 | 0.86547298 |
| 72 | PLK1 | 0.84007296 |
| 73 | ZAP70 | 0.82869211 |
| 74 | MARK2 | 0.82478999 |
| 75 | IRAK4 | 0.78003582 |
| 76 | MAP3K3 | 0.77750294 |
| 77 | FLT3 | 0.77307204 |
| 78 | CHEK2 | 0.77044391 |
| 79 | MAP3K13 | 0.76520431 |
| 80 | STK38L | 0.76370674 |
| 81 | PDK3 | 0.74901790 |
| 82 | PDK4 | 0.74901790 |
| 83 | MAP3K11 | 0.71424707 |
| 84 | LIMK1 | 0.70904463 |
| 85 | MAP2K2 | 0.66537755 |
| 86 | TYK2 | 0.65738984 |
| 87 | PTK2 | 0.64654971 |
| 88 | IRAK1 | 0.64471641 |
| 89 | CHUK | 0.60170144 |
| 90 | TAOK2 | 0.58846003 |
| 91 | NEK1 | 0.55501396 |
| 92 | EPHA3 | 0.55339690 |
| 93 | ARAF | 0.54777887 |
| 94 | MARK3 | 0.52732110 |
| 95 | AURKB | 0.52271622 |
| 96 | SIK3 | 0.52265255 |
| 97 | NME2 | 0.52130679 |
| 98 | BCKDK | 0.49581074 |
| 99 | MAP2K1 | 0.49246095 |
| 100 | AKT2 | 0.48568090 |
| 101 | BCR | 0.48554908 |
| 102 | MAP3K1 | 0.48060423 |
| 103 | STK24 | 0.48027084 |
| 104 | PTK6 | 0.47191620 |
| 105 | DYRK2 | 0.45814959 |
| 106 | LRRK2 | 0.43797283 |
| 107 | TRPM7 | 0.42669439 |
| 108 | RPS6KL1 | 0.41945912 |
| 109 | RPS6KC1 | 0.41945912 |
| 110 | STK38 | 0.41747373 |
| 111 | PDK2 | 0.41685821 |
| 112 | EPHB2 | 0.41338114 |
| 113 | CSK | 0.40479924 |
| 114 | TESK1 | 0.39617057 |
| 115 | PKN2 | 0.39600531 |
| 116 | EEF2K | 0.38260568 |
| 117 | JAK3 | 0.38116984 |
| 118 | CDC42BPA | 0.37825089 |
| 119 | CDK9 | 0.36667676 |
| 120 | RIPK4 | 0.35608485 |
| 121 | WEE1 | 0.35578452 |
| 122 | PAK1 | 0.35517849 |
| 123 | EIF2AK2 | 0.35393238 |
| 124 | CHEK1 | 0.34988502 |
| 125 | ERBB2 | 0.34594087 |
| 126 | FGR | 0.34051297 |
| 127 | ILK | 0.32817387 |
| 128 | CSNK1E | 0.32323591 |
| 129 | RPS6KA5 | 0.31982828 |
| 130 | VRK1 | 0.31277244 |
| 131 | MAPKAPK2 | 0.30992275 |
| 132 | HCK | 0.30817446 |
| 133 | RPS6KA6 | 0.30682860 |
| 134 | BMX | 0.30535730 |
| 135 | RPS6KA2 | 0.30252310 |
| 136 | TAOK1 | 0.29965841 |
| 137 | MTOR | 0.29660135 |
| 138 | MAPK12 | 0.29218760 |
| 139 | RPS6KA1 | 0.29044167 |
| 140 | PRKCD | 0.28660456 |
| 141 | IGF1R | 0.28012042 |
| 142 | NEK2 | 0.27939699 |
| 143 | MAP3K8 | 0.25522974 |
| 144 | ALK | 0.25062201 |
| 145 | BRAF | 0.24511139 |
| 146 | FRK | 0.23767549 |
| 147 | MINK1 | 0.22745454 |
| 148 | PIK3CG | 0.21168013 |
| 149 | YES1 | 0.20585319 |
| 150 | MAP3K7 | 0.17874866 |
| 151 | PRKACA | 0.16671605 |
| 152 | DYRK3 | 0.15638105 |
| 153 | PRKACG | 0.15423450 |
| 154 | ITK | 0.15287522 |
| 155 | CDK2 | 0.14772164 |
| 156 | SRPK1 | 0.12727016 |
| 157 | BLK | 0.12472601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.35184627 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.49716252 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.61689220 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.51477398 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.28069608 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27237547 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.96682257 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.81420746 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.67084580 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 2.67024996 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.64991850 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.45157527 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.33522070 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.24045294 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.22458526 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19097401 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16916849 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 2.16106749 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.04945715 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92665750 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77192033 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66711589 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53310635 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53037961 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.47598353 |
| 26 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.47124265 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46748118 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45677721 |
| 29 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.42001335 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40790225 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.40089181 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.40069714 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.33937543 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32807046 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29663047 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24878384 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.23539061 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21117434 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21049049 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20639081 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17082658 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15373457 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14443742 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.12177083 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.11388185 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10220731 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09495687 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07342084 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06066187 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05172648 |
| 51 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.04994269 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03868422 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99968360 |
| 54 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.99943459 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.98980906 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.97817235 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.95058359 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94828723 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93497774 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92350913 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91594578 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90418403 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89770867 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89347084 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89195636 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88281854 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.86066539 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 0.85252993 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79164653 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78824429 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78758243 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78271138 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77318620 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.75953315 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.75402824 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72399230 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72361978 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72225532 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72087342 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71971127 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70794113 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70759785 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70649486 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.70312391 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69458319 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68774881 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68637798 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68500809 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65687313 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63474550 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62988676 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62948560 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.61882835 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.58783254 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58027087 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56788416 |
| 97 | Melanoma_Homo sapiens_hsa05218 | 0.56429418 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55926709 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.55347108 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.55134746 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.54672462 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.54600666 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53596004 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53483033 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53379157 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52860389 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52507851 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52133137 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51372970 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50874108 |
| 111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50635076 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50397397 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50102355 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48452426 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48172477 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.43963476 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.42707699 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.42525453 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42408593 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.41598348 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41231714 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40548335 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40273578 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.40135434 |
| 125 | DNA replication_Homo sapiens_hsa03030 | 0.38864628 |
| 126 | Homologous recombination_Homo sapiens_hsa03440 | 0.38136974 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.37998029 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37798706 |
| 129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36225949 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35602520 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33821094 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33486492 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.32143802 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30504267 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30339926 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30255693 |
| 137 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30174986 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29277939 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28955784 |
| 140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28542755 |
| 141 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28461401 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27323496 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27224762 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.25456877 |
| 145 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24349202 |
| 146 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24113458 |
| 147 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23496023 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22691805 |
| 149 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.21841496 |
| 150 | Mismatch repair_Homo sapiens_hsa03430 | 0.21789360 |
| 151 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21771728 |
| 152 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.20991229 |
| 153 | Apoptosis_Homo sapiens_hsa04210 | 0.20707861 |
| 154 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20492613 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20041318 |
| 156 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20018657 |
| 157 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18664623 |
| 158 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17880003 |
| 159 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16894825 |

